Email ID
Sign me in automatically next time
Sanofi strengthens biosurgery offering with Pluromed acquisition

Sanofi has agreed to buy surgical gel developer Pluromed for an undisclosed fee, bolstering the biosurgical portfolio it gained with its acquisition of Genzyme last year.

16 March 2012
Madeleine Armstrong

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36